Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Beckman Coulter Launches Fully Automated Platform to Streamline High-Throughput Urinalysis

By LabMedica International staff writers
Posted on 28 Jul 2026

Urinalysis is among the most frequently ordered diagnostics in emergency, inpatient, and primary care, yet many laboratories still rely on fragmented, manual workflows. More...

Rising test volumes linked to diabetes, chronic kidney disease, and urinary tract infections are increasing demands for throughput and standardization. Core and reference laboratories also face variability and staffing strain from manual microscopic review. A new fully automated urinalysis system has now been introduced to address these workflow pressures.

Beckman Coulter Diagnostics has launched the DxU 1800 System in the United States, unveiling it at the Association for Diagnostics & Laboratory Medicine (ADLM) Annual Scientific Meeting & Clinical Lab Expo. The platform combines a new urine chemistry analyzer and dedicated consumables with the company’s proven microscopy technology. It is intended to help laboratories deliver standardized results at scale to support confident clinical decision-making.

The system integrates the DxU 1800c Chemistry analyzer with a DxU Iris Microscopy analyzer, unifying chemical analysis and particle imaging on a single high-throughput platform. By automating and connecting these processes, the workflow reduces manual handoffs and supports greater consistency between chemistry and microscopy. Automated urine microscopy is described as reducing manual microscopic review rates to less than 3%, which is designed to improve throughput and reduce variability.

As a standalone unit, the DxU 1800c Chemistry analyzer processes up to 300 samples per hour. It supports storage of up to 2,000,000 samples and 100,000 strip images, and it displays strip image results on screen for review. In integrated use, the system is positioned to help laboratories scale operations with greater control by aligning chemistry and microscopy outputs.

Urine testing is widely utilized across care settings, with approximately one in three U.S. emergency department visits including a urine test and nearly half of admissions involving urinalysis. In non-acute care, up to 87% of primary care patients receive urine testing, and the test consistently ranks among the ten most-ordered assays. These patterns, together with rising burdens of diabetes, chronic kidney disease, and urinary tract infections, are increasing demand for standardized, high-throughput urinalysis.

Beckman Coulter Diagnostics indicates that an expanded chemistry menu is planned to include creatinine and microalbumin assays, which may provide additional kidney function insight as part of routine screening testing without requiring changes to existing laboratory workflow. The DxU 1800 System will be showcased at the ADLM 2026 Clinical Lab Expo in the Danaher booth (#3237). The platform is part of a connected ecosystem intended to streamline end-to-end urinalysis.

“Despite urinalysis’s essential role and growing volume trends, many laboratories still rely on workflows requiring manual review, fragmented processes or separate chemistry and microscopy systems. As testing shifts to larger core and reference labs, these inefficiencies can create bottlenecks, variability and staffing strain. The DxU 1800 System helps standardize testing, increase throughput and reduce manual microscopy, empowering laboratories to deliver consistent results that enable confident clinical decisions at scale,” said Matthew Rhyner, Vice President and Managing Director, Hematology and Urinalysis Business for Beckman Coulter Diagnostics.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.